Ignite Creation Date:
2025-12-25 @ 3:05 AM
Ignite Modification Date:
2025-12-31 @ 11:27 AM
Study NCT ID:
NCT00809133
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2008-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neoplasms | View |
Keywords: